Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Salix Pharmaceuticals is a specialty pharmaceutical company dedicated to the prevention and treatment of gastrointestinal (GI) diseases. Acquired by Bausch Health Companies Inc. in 2015, Salix operates as a significant business unit, focusing on providing innovative solutions for patients and healthcare professionals in the gastroenterology sector. Their portfolio includes well-known treatments for conditions such as irritable bowel syndrome with diarrhea (IBS-D), hepatic encephalopathy (HE), and opioid-induced constipation (OIC).
Serves as the primary operational hub for Salix Pharmaceuticals within the U.S., overseeing commercial activities, product strategy, medical affairs, and administrative support for its gastroenterology portfolio, under the Bausch Health corporate structure.
Modern corporate office facilities located within the Somerset Corporate Center, known for its Class A office space, campus amenities, and accessibility.
As part of Bausch Health, the work culture at the Bridgewater site is focused on innovation in pharmaceuticals, patient-centricity, and achieving performance-driven results. Employees typically experience a dynamic and fast-paced environment with opportunities for professional development within the larger Bausch Health organization.
This location is central to Salix's U.S. market leadership in gastroenterology, facilitating the management and distribution of its core products, R&D oversight, and engagement with the healthcare community.
While Salix Pharmaceuticals' primary market focus is the United States, its products are made available in various international markets through Bausch Health's extensive global distribution network. Bausch Health manages the global commercialization, regulatory affairs, supply chain, and market access for Salix's portfolio of GI treatments in numerous countries where they are approved and marketed.
400 Somerset Corporate Blvd
Bridgewater
New Jersey
USA
Address: 8510 Colonnade Center Dr, Suite 200, Raleigh, NC 27615, USA
Leverages the rich life sciences ecosystem of the Research Triangle Park area, supporting Salix's product development initiatives and commercial activities in the region.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Salix Pharmaceuticals' leadership includes:
Salix Pharmaceuticals has been backed by several prominent investors over the years, including:
In the last twelve months, the most notable executive change impacting Salix Pharmaceuticals was the appointment of a new Chief Executive Officer for its parent company, Bausch Health. Such leadership transitions at the parent company level are pivotal for the strategic direction and oversight of its subsidiary businesses, including Salix.
Discover the tools Salix Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Email addresses for employees at Salix Pharmaceuticals generally follow the conventions of its parent company, Bausch Health. The most common format is typically a combination of the employee's first and last name. Some Salix-specific roles or legacy communications might also utilize a @salix.com domain.
Common formats include [first].[last]@bauschhealth.com (e.g., john.doe@bauschhealth.com) or [f][last]@bauschhealth.com (e.g., jdoe@bauschhealth.com). Potentially, [first].[last]@salix.com (e.g., jane.doe@salix.com) may also be in use.
Format
robert.spurr@bauschhealth.com
Example
75%
Success rate
Bausch Health News Releases • February 22, 2024
Bausch Health announced its fourth-quarter and full-year 2023 financial results, highlighting continued revenue growth in its Salix segment. Key products such as XIFAXAN® and TRULANCE® were noted as significant contributors to the segment's robust performance....more
Bausch Health News Releases • October 25, 2023
Salix Pharmaceuticals announced it would present 17 scientific posters featuring new data on XIFAXAN® (rifaximin). The presentations covered its use for irritable bowel syndrome with diarrhea (IBS-D) and overt hepatic encephalopathy (OHE) at the ACG 2023 Annual Scientific Meeting....more
Bausch Health News Releases • May 4, 2023
Salix Pharmaceuticals highlighted its ongoing dedication to the field of gastroenterology by presenting a wide range of data from its diverse GI portfolio at the Digestive Disease Week® (DDW) 2023 conference. The presentations included findings related to conditions such as IBS-D and HE....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Salix Pharmaceuticals, are just a search away.